Literature DB >> 30375571

Management Decisions for Rheumatoid Arthritis After Tumor Necrosis Factor Alpha Antagonist-Induced Lupus-Like Syndrome.

Alexa Meara1, Ruth Chan1, Matthew Husa1.   

Abstract

Entities:  

Year:  2016        PMID： 30375571      PMCID： PMC6190982          DOI： 10.5606/ArchRheumatol.2016.5904

Source DB:  PubMed          Journal:  Arch Rheumatol        ISSN： 2148-5046            Impact factor:   1.472


× No keyword cloud information.
  7 in total

Review 1.  A case of infliximab-induced lupus in a patient with ankylosing spondylitis: is it safe switch to another anti-TNF-α agent?

Authors:  Tânia Santiago; Mariana Galante Santiago; João Rovisco; Cátia Duarte; Armando Malcata; José António Pereira da Silva
Journal:  Clin Rheumatol       Date:  2013-08-17       Impact factor: 2.980

Review 2.  TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists.

Authors:  Victoria L Williams; Philip R Cohen
Journal:  Int J Dermatol       Date:  2011-05       Impact factor: 2.736

Review 3.  Drug-induced lupus due to anti-tumor necrosis factor alpha agents.

Authors:  Michelle F Costa; Nuha R Said; Bernard Zimmermann
Journal:  Semin Arthritis Rheum       Date:  2007-10-30       Impact factor: 5.532

4.  Is the risk of tumour necrosis factor inhibitor-induced lupus or lupus-like syndrome the same with monoclonal antibodies and soluble receptor? A case/non-case study in a nationwide pharmacovigilance database.

Authors:  Guillaume Moulis; Agnès Sommet; Maryse Lapeyre-Mestre; Jean-Louis Montastruc
Journal:  Rheumatology (Oxford)       Date:  2014-06-04       Impact factor: 7.580

Review 5.  Anti-TNF-induced lupus.

Authors:  Emma L Williams; Stephan Gadola; Christopher J Edwards
Journal:  Rheumatology (Oxford)       Date:  2009-05-04       Impact factor: 7.580

Review 6.  Autoimmune diseases induced by TNF-targeted therapies.

Authors:  Manuel Ramos-Casals; Pilar Brito-Zerón; Maria-Jose Soto; Maria-Jose Cuadrado; Munther A Khamashta
Journal:  Best Pract Res Clin Rheumatol       Date:  2008-10       Impact factor: 4.098

7.  Anti-Tumor Necrosis Factor-α Induced Systemic Lupus Erythematosus().

Authors:  Hani Almoallim; Yahya Al-Ghamdi; Haneen Almaghrabi; Omnia Alyasi
Journal:  Open Rheumatol J       Date:  2012-11-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.